InvestorsHub Logo
Followers 7
Posts 611
Boards Moderated 0
Alias Born 06/23/2020

Re: dloggold post# 12489

Friday, 07/31/2020 2:13:55 PM

Friday, July 31, 2020 2:13:55 PM

Post# of 43139
My (probably over optimistic) theory is that they don't want to specifically say Lenzilumab/Humanigen until we are listed on a more reputable exchange and interim phase 3 trial data released to the public.

Could it be possible they are just thinking about the narrative of how will it make the NIH look if they have initiated & backed a trial with "Parma bro's" old company that is listed on the OTC market and they have no trial data other than a 12 patient study to back up the drugs efficacy? A main talking point of Fauci is that they are not cutting corners with these trials, I think they are just getting their ducks in a row before this hits the papers.

The other possibility is that humanigen is entirely fake and everything they are releasing is fake, haha. That's the chance you take when investing on the OTC, but I think this boards research suggest we are past that.
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.